Malaria drug study for children in Papua New Guinea
Treatments studied
Part of Infections clinical trials.
This trial tests a medicine called tafenoquine, which is used to treat malaria. It aims to see how well it works in children with uncomplicated malaria, and participants will also receive standard malaria treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must have a confirmed diagnosis of uncomplicated malaria from a blood test
- Must have normal levels of an enzyme called G6PD (a blood test will check this)
- Must not have severe malaria or any other major health problems
- Must not be allergic to any of the study medicines, including primaquine, artemether-lumefantrine, or dihydroartemisinin-piperaquine
- Must be able to attend all follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how the malaria medicine tafenoquine works in healthy children in Papua New Guinea. It may help find the right dose to prevent malaria safely.
This study tests a medicine given to mothers after childbirth to see how it passes into breast milk and if it is safe for babies. It may help prevent malaria relapse in mothers who have had vivax malaria.
This trial tests if giving two malaria medicines together (dihydroartemisinin piperaquine and primaquine) to everyone in a community can help reduce malaria. It is for people living in high-risk areas in eastern Ghana.
This study tests how the malaria medicine tafenoquine is processed in the bodies of young children with vivax malaria. It helps find the right dose for small children and ensures the treatment is safe and effective.
This trial tests a revised dose of a medicine called tafenoquine to more effectively cure vivax malaria (a type of malaria that can come back). It is for people with normal G6PD enzyme levels and a current fever from vivax malaria.
This study tests different schedules of a malaria prevention medicine to see which works best for improving school attendance, learning, and executive function in children aged 6 to 10 in Siaya County, Kenya.
Hear when a new Uncomplicated Malaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.